Phillips et al identified prognostic risk groups for patients with HTLV-1-associated adult T-cell Leukemia/Lymphoma. This can help to identify a patient who may benefit from more aggressive management. The authors are from Columbia University and multiple cancer centers in New York.
Parameters:
(1) ECOG performance status
(2) Ann Arbor stage
(3) serum calcium in mg/dL
(4) age in years
ECOG |
Ann Arbor Stage |
Serum Calcium |
Age in Years |
Risk Group |
0 or 1 |
Stage I or II |
NA |
NA |
low |
0 or 1 |
Stage III or IV |
NA |
NA |
intermediate |
2 to 4 |
NA |
<= 11 mg/dL |
<= 60 |
intermediate |
2 to 4 |
NA |
<= 11 mg/dL |
> 60 |
high |
2 to 4 |
NA |
> 11 mg/dL |
NA |
high |
Risk Group |
Median Overall Survival |
low |
157 weeks |
intermediate |
45 weeks |
high |
13 weeks |
Specialty: Hematology Oncology
ICD-10: ,